Effect of statistical uncertainty on Monaco Monte-Carlo dose calculation
Purpose: The aim of this study is to evaluate influence of statistical uncertainty on Monte-Carlo dose calculation of Monaco 5.11 treatment planning system (TPS).
Methods: Phantom with contoured C-Shape structure set was downloaded from AAPM website provided with TG119 report. VMAT plan was created for C-Shape test case using Monaco TPS for 6 MV Elekta Versa-HD linear-accelerator. Dose prescription and constraints were as per TG119. After optimizations, C-Shape plan was calculated with different statistical-uncertainty (i) 0.5%, 1.0%, 3.0% and 5.0% per control point and (ii) 0.5%, 1.0%, 3.0% and 5.0% per calculation. Base plan was calculated with 0.5% per control point.
Results: Variations in PTV doses for different statistical-uncertainties with respect to 0.5% per control point were within PTV-D95: 82 cGy(1.64%); PTV-D10: 14.8 cGy(0.28%); Core-D10: 3.7 cGy(0.15%). MU required to deliver a plan (920 MU) were observed same with different statistical-uncertainty. Calculation time increases with decrease in statistical-uncertainty due to more number of histories. 2D-Gamma pass rate was ranging from 98.1% to 98.9% for analyzed statistical-uncertainties. Statistical-uncertainty 0.5% per control point showed higher Gamma pass-rate (98.9%).
Conclusion: Minor variation (<1.64%) in dose volume parameters was observed with different statistical-uncertainties, whereas Monitor unit remain same. 3.0% per control point and 0.5% per calculation resulted in almost similar results and found optimal with reasonable calculation time in terms of plan quality and delivery accuracy (gamma pass-rate).
Palta J, Mackie TR. Intensity-Modulated Radiation Therapy- The State of the Art. AAPM Medical Physics Monograph No. 29, Medical Physics Publishing, Madison, WI, USA, 2003.
Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy. Phys Med Biol. 1995;40(9):1435-49.
Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310-7.
Chetty IJ, Curran B, Cygler JE, et al. Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys. 2007;34(12):4818-53.
Fippel M. 2006. Monte Carlo Dose Calculation for Treatment Planning. New Technologies in Radiation Oncology Medical Radiology. Heidelberg: Springer; 2006:197-206.
Narayanasamy G, Saenz D, Cruz W, et al. Commissioning an Elekta Versa HD linear accelerator. J Appl Clin Med Phys. 2016;17(1):5799.
Snyder M, Halford R, Knill C, et al. Modeling the Agility MLC in the Monaco treatment planning system. J Appl Clin Med Phys. 2016;17(3):6044.
Ezzell GA, Burmeister JW, Dogan N, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009;36(11):5359-73.
Low DA, Harms WB, Mutic S. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25:656-61.
Kawrakow I. The effect of Monte Carlo statistical uncertainties on the evaluation of dose distributions in radiation treatment planning. Phys Med Biol. 2004;49(8):1549-56.
Kawrakow I, Fippel M. Investigation of variance reduction techniques for Monte Carlo photon dose calculation using XVMC. Phys Med Biol. 2000;45(8):2163-83.
Alshaikhi J. Influence on different Monte-Carlo variances at the dose calculation and the impact to the commissioning. MS thesis. 2010.
Monaco®. Introduction to Monaco IMRT. Monaco® Training Guide.2008.
Sarkar B, Manikandan A, Nandy M, et al. Influence of monte carlo variance with fluence smoothing in VMAT treatment planning with Monaco TPS. Indian J Cancer. 2016;53(1):158-61.
Chetty IJ, Rosu M, Kessler ML, et al. Reporting and analyzing statistical uncertainties in Monte Carlo-basedtreatment planning. Int J Radiat Oncol Biol Phys. 2006;65(4):1249-59.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.